학술논문
A Phase II study to assess the safety and efficacy of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER positive locally advanced or metastatic breast cancer patients (IRIS) - Trial Results.
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755